NASDAQ:CODX - Co-Diagnostics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $2.63 -0.12 (-4.36 %) (As of 09/21/2018 04:00 PM ET)Previous Close$2.63Today's Range$2.63 - $2.8052-Week Range$1.45 - $6.85Volume23,303 shsAverage Volume383,148 shsMarket Capitalization$26.78 millionP/E RatioN/ADividend YieldN/ABetaN/A Company ProfileDiscussionChartFinancialsInsider TradesHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Co-Diagnostics, Inc., a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. Co-Diagnostics, Inc. was founded in 2013 and is headquartered in Salt Lake City, Utah. Receive CODX News and Ratings via Email Sign-up to receive the latest news and ratings for CODX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Diagnostics & Research Sub-IndustryN/A SectorMedical SymbolNASDAQ:CODX CUSIPN/A Webcodiagnostics.com Phone+1-801-2789769 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins-149,750.40% Return on Equity-3,935.44% Return on Assets-479.06% Miscellaneous EmployeesN/A Outstanding Shares11,920,000Market Cap$26.78 million Co-Diagnostics (NASDAQ:CODX) Frequently Asked Questions What is Co-Diagnostics' stock symbol? Co-Diagnostics trades on the NASDAQ under the ticker symbol "CODX." Who are some of Co-Diagnostics' key competitors? Some companies that are related to Co-Diagnostics include Oncimmune (ONC), Profound Medical (PRN), Lexagene (LXG), Sernova (SVA), SQI Diagnostics (SQD), Parallax Health Sciences (PRLX), Cambridge Cognition (COG), LED Medical Diagnostics (LMD), 3D Signatures (DXD), GeneNews (GEN), Deepmatter Group (DMTR), Genedrive (GDR), Eternity Healthcare (ETAH), Imaging Dynamics (IDL) and Med Biogene (MBI). Who are Co-Diagnostics' key executives? Co-Diagnostics' management team includes the folowing people: Mr. Dwight H. Egan, Chairman, CEO & Pres (Age 65)Dr. Brent C. Satterfield, Co-Founder, Chief Science Officer & Director (Age 41)Mr. Reed L. Benson, CFO, Gen. Counsel & Sec. (Age 70) When did Co-Diagnostics IPO? (CODX) raised $9 million in an initial public offering (IPO) on Thursday, July 13th 2017. The company issued 1,300,000 shares at $6.35-$6.75 per share. WallachBeth Capital and Network 1 Securities acted as the underwriters for the IPO. How do I buy shares of Co-Diagnostics? Shares of CODX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Co-Diagnostics' stock price today? One share of CODX stock can currently be purchased for approximately $2.63. How big of a company is Co-Diagnostics? Co-Diagnostics has a market capitalization of $26.78 million. What is Co-Diagnostics' official website? The official website for Co-Diagnostics is http://codiagnostics.com/. How can I contact Co-Diagnostics? Co-Diagnostics' mailing address is 4049 S Highland Dr, SALT LAKE CITY, UT 84124-1664, United States. The company can be reached via phone at +1-801-2789769. MarketBeat Community Rating for Co-Diagnostics (NASDAQ CODX)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 106 (Vote Outperform)Underperform Votes: 102 (Vote Underperform)Total Votes: 208MarketBeat's community ratings are surveys of what our community members think about Co-Diagnostics and other stocks. Vote "Outperform" if you believe CODX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CODX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 9/22/2018 by MarketBeat.com StaffFeatured Article: Is the Dow Jones Industrial Average (DJIA) still relevant?